Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

  • Bioptigen Inc.

Apr 2012
Technology company Bioptigen Inc. of Durham, N.C., has received clearance from Health Canada to begin marketing its handheld ophthalmic imaging systems for patient use. The Envisu series spectral domain ophthalmic imaging system uses low-power near-infrared light to produce high-resolution depth-resolved images of eye structures in real time. Based on OCT technology, the systems are expected to enable greater understanding of eye disease progression, detection and treatment. “Now that Bioptigen has regulatory approval to market our technology in Canada and the European Union, adults and children can begin benefiting from this flexible and detailed imaging platform that complements existing diagnostic techniques and treatments,” said Eric Buckland, president and CEO.

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!